Research-use context: “What it is used for” below means what scientists and clinical researchers have investigated—not an instruction or recommendation for personal use.
What researchers study
CJC-1295 is a long-acting growth-hormone-releasing hormone analogue, while ipamorelin is a selective growth-hormone secretagogue. Researchers study the pair for effects on GH/IGF-1 signaling, body composition, recovery and muscle biology.
Potential side effects & unknowns
Human data for the combination itself are limited. CJC-1295 studies increased GH and IGF-1 and reported no serious adverse reactions in small early trials, but GH/IGF-1 stimulation can plausibly affect glucose handling, fluid retention, joint symptoms and other endocrine pathways.
Research highlight
Controlled human studies of CJC-1295 showed sustained increases in GH and IGF-1 after dosing. Evidence for the specific CJC-1295/ipamorelin combination is much thinner and includes preclinical rather than strong human outcome studies.
Related video
Dr. Jones, DC: The BEST Peptide Stack for Building Muscle (CJC-1295 + Ipamorelin)
Additional commentary from Dr. Dean Jones, DC. This video is embedded for context and education; WILGO does not control or independently verify claims made in third-party videos.
Independent third-party content: Dr. Dean Jones, DC, is not affiliated with WILGO or WILGO's suppliers. Embedding his publicly available video does not imply sponsorship, endorsement, partnership, or approval by Dr. Jones, WILGO, or any supplier.
Video hosted by YouTube. Opening or playing it may be subject to YouTube's privacy terms.
Looking for CJC-1295 + IPA?
Follow the tracked WILGO product link to see current inventory, exact product specifications and checkout pricing.
View Current Product →